High-level gentamicin-resistant enterococci: In vitro activity of double and triple combinations of antimicrobial drugs

Chemotherapy

Volumn 42, Issue 1, 1996, Pages 37-46

  Ferrara, A ^a   Santos Dos, C ^a   Cimbro, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antimicrobial combinations; Gentamicin; High level gentamicin resistant enterococci; Meropenem; Sparfloxacin; Teicoplanin

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; MEROPENEM; SPARFLOXACIN; TEICOPLANIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTI-INFECTIVE AGENTS; ANTIBIOTICS, AMINOGLYCOSIDE; ANTIBIOTICS, COMBINED; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; IN VITRO; MICROBIAL SENSITIVITY TESTS; QUINOLONES; TEICOPLANIN;

EID: 0029655450     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239420     Document Type: Article

References (26)

1. Eliopoulos GM, Eliopoulos CT: Therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis 1990;9:118-126.
2. Herman DJ, Gerding DN: Antimicrobial resistance among enterococ-ci. Antimicrob Agents Chemothcr 1991;35:1-4.
3. Moellering RC Jr: The cnterococ-cus: A classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Che-mother 1991:28:1-12.
4. Moellering RC Jr. Krogstad DJ: Antibiotic resistance in entcrococci: in Schlessinger D (cd): Microbiologv-1979. Washington. American Society for Microbiology. 1979. pp 293-298.
5. Calderwood SA, Wennersten C, Moellering RC Jr, Kunz U, Krogstad DJ: Resistance to six aminoglycoside aminocyclitol antibiotics among enterococci: Prevalence, evolution and relationship to synergism with penicillin. Antimicrob Agents Chemother 1977;12:401-405.
6. Moellering RC Jr, Wennersten C, Weinberg AN: Studies on antibiotic synergism against enterococci: Bactériologie studies. J Lab Clin Med 1971;77:821-828.
7. Moellering RC Jr, Wennersten C, Weinstein AJ: Pcnicillin-tobramy-cin synergism against enterococci: A comparison with penicillin and gcn-tamicin. Antimicrob Agents Chemother 1973;3:526-529.
8. Chen HY, Williams JD:Theactivity of vancomycin and tcicoplanin alone and in combination with gen-tamicin or ampicillin against Streptococcus faecalis.Eur J Clin Microbiol 1984;3:436-438.
9. Tuazon CU, Miller H: Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci. Antimicrob Agents Chemother 1984:25:411-412.
10. Murray BE, Medcrski-Samoraj BD: Transferable beta-lactamase: A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.J Clin Invest 1983;72:1168-1171.
11. Horodniceanu T, Bouguelercl L, El-Solh N, Bieth G, Dclbos F: High-level, plasmid-borne resistance to gen-tamicin in Streptococcus faecalis subspecies -ymogenes.Antimicrob Agents Chemother 1979:16:686-689.
12. Shlaes DM. Bouvet A, Devine C, Shlaes JH, Al-Obeid S, Williamson R: Inducible, transferable resistance to vancomycin in Enterococcus faecalis A 256. Antimicrob Agents Che-mother 1989;33:198-203.
13. Coudron PE, Mayhall CG, Facklam RR, Spadora AC, Lamb VA, Ly-brand MR, Dalton HP: Streptococcus faecium outbreak in a neonatal intensive care unit, iClin Microbiol 1984;20:1044-1048.
14. Zervos MJ, Dembinski S, Mikescll TS, Schabcrg DR: High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986:153:1075-1083.
15. Zervos MJ, Kauffman CA, Therasse PM, Bergman BS, Mikescll TS, Schabcrg DR: Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intem Med 1987:106: 687-691.
16. Woodford N, McNamara E, Smyth E, George RC: High-level resistance to gentamicin in Enterococcus faecium.J Antimicrob Chemother 1992;29:395-403.
17. Yu VL, Felcgic TP, Yee RB, Pas-culle AW, Taylor FH: Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltopliilia. JInfect Dis 1980;142:602-607.
18. Bercnbaum MC, Yu VL, FelegieTP: Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother 1983,12: 555-563.
19. Debbia E, Pesce A, Schito GC: In vitro interactions between teico-planin and other antibiotics against enterococci and staphylococci. J Hosp Infect 1986;7(suppl A):73-77.
20. Traub WH, Leonhard B, Bauer D: Enterococcus faecalis: In vitro activity of antimicrobial drugs, singly and combined, with and without de-fibrinated human blood, against high-level gentamicin-resistant isolates. Chemotherapy 1993,39:248-253.
21. Traub WH, Spohr M, Bauer D: Streptococcus faecalis: In vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood. Chemotherapy 1986;32:270-285.
22. Neu HC, Labthavikul P: In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother 1983; 24:425-428.
23. Shanson DC, Tadayon M: Activity of tcicoplanin compared with vancomycin alone, and combined with gentamicin. against penicillin-tolerant viridans streptococci and entc-rococci causing endocarditis. J Hosp Infect 1986;7(suppl A):65-72.
24. Canawati HN, Sapico FL, Ginunas VJ, Khawam S: Ampicillin-resistant enterococci: Time-kill study using antpicillin. vancomycin, imipenem. ciprofloxacin and gentamicin, alone and in selected combinations. Adv Ther 1986;3:59-67.
25. Ünal S, Flokowitsch J, Mullen DL, Preston DA, Nicas Tl: In vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enlcrococcal isolates. J Antimicrob Chemother 1993;31: 711-723.
26. Shlaes DM, Etter L, Gutmann L: Synergistic killing of vancomycin-resistant enterococci of classes A, B and C by combinations of vancomycin, penicillin and gentamicin. Antimicrob Agents Chemother 1991: 35:776-779.